(140,287)(114,846)Other income (expense), net
7,256(2,322)Debt extinguishment loss
(42,347)(29,891)(Loss) income before provision for income taxes
(61,661)227,386Provision for income taxes
11,97370,236Net (loss) income
57,150Net (loss) income per share: Basic
.59Weighted average number of shares outstanding:Basic
264,041264,305(1) Stock-based compensation included in costs and expenses during the twelve months ended September 29, 2012 was $5,722 for cost of revenues, $5,328 for research and development, $7,355 for selling and marketing, $18,667 for general and administrative and $3,500 for restructuring. Stock-based compensation included in costs and expenses during the twelve months ended September 24, 2011 was $4,602 for cost of revenues, $4,852 for research and development, $5,954 for selling and marketing, and $20,064 for general and administrative.
HOLOGIC, INC.RECONCILIATION OF GAAP REVENUES, EPS AND NET (LOSS) INCOME TO NON-GAAP ADJUSTED REVENUES, EPS, NET INCOME AND EBITDA(Unaudited)(In thousands, except earnings per share)Three Months EndedSeptember 29, 2012September 24, 2011REVENUESGAAP revenues
$ 588,548Adjustment related to Novartis collaboration
11,606Non-GAAP adjusted revenues
|SOURCE Hologic, Inc.|
Copyright©2012 PR Newswire.
All rights reserved